VANI•benzinga•
Vivani Medical Expands Collaboration With Okava Pharmaceuticals To Include Dogs In Development Of OKV-119, A Long-Acting Glp-1 Therapy For Weight Management, Diabetes and Other Cardiometabolic Conditions
Summary
No summary available.
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on April 15, 2025 by benzinga